Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    July 2020
  1. MENDOZA DP, Heeger A, Mino-Kenudson M, Lanuti M, et al
    Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23835.
    PubMed     Abstract available


  2. MORTANI BARBOSA EJ JR, Yang R, Hershman M
    Real World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    AJR Am J Roentgenol. 2020 Jul 15. doi: 10.2214/AJR.20.23637.
    PubMed     Abstract available


    June 2020
  3. LI Q, Li X, Li XY, Huo JW, et al
    Spectral CT in Lung Cancer: Usefulness of Iodine Concentration for Evaluation of Tumor Angiogenesis and Prognosis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.22688.
    PubMed     Abstract available


  4. BANKS KP, Peacock JG, Gusman M, Clemenshaw MN, et al
    It's About Quality, Not Quantity: Qualitative FDG PET/CT Criteria for Therapy Response Assessment in Clinical Practice.
    AJR Am J Roentgenol. 2020 Jun 17:1-12. doi: 10.2214/AJR.19.22642.
    PubMed     Abstract available


    April 2020
  5. TAU N, Stundzia A, Yasufuku K, Hussey D, et al
    Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
    AJR Am J Roentgenol. 2020 Apr 29:1-6. doi: 10.2214/AJR.19.22346.
    PubMed     Abstract available


  6. CHU ZG, Li WJ, Fu BJ, Lv FJ, et al
    CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
    AJR Am J Roentgenol. 2020 Apr 29:1-8. doi: 10.2214/AJR.19.22381.
    PubMed     Abstract available


  7. SORENSEN L, Nielsen M, Petersen J, Pedersen JH, et al
    Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial.
    AJR Am J Roentgenol. 2020 Apr 7:1-11. doi: 10.2214/AJR.19.22300.
    PubMed     Abstract available


    March 2020
  8. MA Y, Byrne SC, Gange C Jr, Hunsaker AR, et al
    Radiologic-Pathologic Correlation for Nondiagnostic CT-Guided Lung Biopsies Performed for the Evaluation of Lung Cancer.
    AJR Am J Roentgenol. 2020 Mar 11:1-5. doi: 10.2214/AJR.19.22244.
    PubMed     Abstract available


    January 2020
  9. ONISHI Y, Kusumoto M, Motoi N, Watanabe H, et al
    Ciliated Muconodular Papillary Tumor of the Lung: Thin-Section CT Findings of 16 Cases.
    AJR Am J Roentgenol. 2020 Jan 22:1-5. doi: 10.2214/AJR.19.21945.
    PubMed     Abstract available


    December 2019
  10. MENDOZA DP, Lin JJ, Rooney MM, Chen T, et al
    Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2019 Dec 30:1-9. doi: 10.2214/AJR.19.21982.
    PubMed     Abstract available


  11. SUH YJ, Park CM, Han K, Jeon SK, et al
    Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    AJR Am J Roentgenol. 2019 Dec 17:1-9. doi: 10.2214/AJR.19.21811.
    PubMed     Abstract available


    November 2019
  12. SHAO X, Niu R, Jiang Z, Shao X, et al
    Role of PET/CT in Management of Early Lung Adenocarcinoma.
    AJR Am J Roentgenol. 2019 Nov 12:1-9. doi: 10.2214/AJR.19.21585.
    PubMed     Abstract available


    October 2019
  13. COLLETTI PM
    Earlier Diagnosis of Subcentimeter Lung Cancers Is Not Self-Evidently Beneficial: Personal Experience.
    AJR Am J Roentgenol. 2019;213:819-820.
    PubMed     Abstract available


  14. REICH JM, Kim JS
    Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers.
    AJR Am J Roentgenol. 2019;213:817-818.
    PubMed     Abstract available


    September 2019
  15. OKAZAKI E, Seura H, Hasegawa Y, Okamura T, et al
    Prognostic Value of the Volumetric Parameters of Dual-Time-Point (18)F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.
    AJR Am J Roentgenol. 2019 Sep 11:1-8. doi: 10.2214/AJR.19.21376.
    PubMed     Abstract available


    August 2019
  16. KIM TH, Woo S, Yoon SH, Halpenny DF, et al
    CT Characteristics of Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2019 Aug 15:1-14. doi: 10.2214/AJR.19.21485.
    PubMed     Abstract available


    July 2019
  17. CHEN L, Smith DA, Somarouthu B, Gupta A, et al
    A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non-Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies.
    AJR Am J Roentgenol. 2019 Jul 30:1-12. doi: 10.2214/AJR.19.21135.
    PubMed     Abstract available


  18. KANDATHIL A, Iii RCS, Subramaniam RM
    Lung Cancer Recurrence: (18)F-FDG PET/CT in Clinical Practice.
    AJR Am J Roentgenol. 2019 Jul 30:1-9. doi: 10.2214/AJR.19.21227.
    PubMed     Abstract available


    June 2019
  19. ZHAN Y, Peng X, Shan F, Feng M, et al
    Attenuation and Morphologic Characteristics Distinguishing a Ground-Glass Nodule Measuring 5-10 mm in Diameter as Invasive Lung Adenocarcinoma on Thin-Slice CT.
    AJR Am J Roentgenol. 2019 Jun 19:1-9. doi: 10.2214/AJR.18.21008.
    PubMed     Abstract available


  20. LEE JH, Yoon SH, Kim YT, Kang CH, et al
    Sleeve Lobectomy for Non-Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome Analysis.
    AJR Am J Roentgenol. 2019 Jun 5:1-10. doi: 10.2214/AJR.19.21258.
    PubMed     Abstract available


  21. LEMPEL JK, Raymond DP
    Intraoperative Percutaneous Microcoil Localization of Small Peripheral Pulmonary Nodules Using Cone-Beam CT in a Hybrid Operating Room.
    AJR Am J Roentgenol. 2019 Jun 5:1-4. doi: 10.2214/AJR.19.21175.
    PubMed     Abstract available


    May 2019
  22. YANG Y, Li K, Sun D, Yu J, et al
    Invasive Pulmonary Adenocarcinomas Versus Preinvasive Lesions Appearing as Pure Ground-Glass Nodules: Differentiation Using Enhanced Dual-Source Dual-Energy CT.
    AJR Am J Roentgenol. 2019 May 13:1-9. doi: 10.2214/AJR.19.21245.
    PubMed     Abstract available


  23. LI WJ, Chu ZG, Zhang Y, Li Q, et al
    Effect of Slab Thickness on the Detection of Pulmonary Nodules by Use of CT Maximum and Minimum Intensity Projection.
    AJR Am J Roentgenol. 2019 May 7:1-6. doi: 10.2214/AJR.19.21325.
    PubMed     Abstract available


    April 2019
  24. OTANI T, Hosono M, Kanagaki M, Onishi Y, et al
    Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.
    AJR Am J Roentgenol. 2019 Apr 17:1-7. doi: 10.2214/AJR.18.20478.
    PubMed     Abstract available


    January 2019
  25. WOO JH, Kim MY, Lee KS, Jeong DY, et al
    Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20519.
    PubMed     Abstract available


  26. LYONS GR, Winokur RS, Pua BB
    Pulmonary Cryoablation Zones: More Aggressive Ablation Is Warranted In Vivo.
    AJR Am J Roentgenol. 2019;212:195-200.
    PubMed     Abstract available


    December 2018
  27. OHNO Y, Yui M, Aoyagi K, Kishida Y, et al
    Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    AJR Am J Roentgenol. 2018 Dec 4:1-9. doi: 10.2214/AJR.18.20111.
    PubMed     Abstract available


  28. GRUDEN JF, Green DB
    Reply to "Appropriate Timing for Follow-Up CT Imaging for Stable Lung CT Screening Reporting and Data System Category 3 Lesions Identified at Baseline Low-Dose CT".
    AJR Am J Roentgenol. 2018;211:W302.
    PubMed    


  29. PANSE PM, Cummings KW, Gotway MB
    Appropriate Timing for Follow-Up CT Imaging for Stable Lung CT Screening Reporting and Data System Category 3 Lesions Identified at Baseline Low-Dose CT.
    AJR Am J Roentgenol. 2018;211:W301.
    PubMed    


    November 2018
  30. OHNO Y, Yui M, Chen Y, Kishida Y, et al
    Gadolinium-Based Blood Volume Mapping From MRI With Ultrashort TE Versus CT and SPECT for Predicting Postoperative Lung Function in Patients With Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2018 Nov 13:1-10. doi: 10.2214/AJR.18.20095.
    PubMed     Abstract available


    September 2018
  31. TU W, Verma R, Krishna S, McInnes MDF, et al
    Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT?
    AJR Am J Roentgenol. 2018 Sep 12:1-7. doi: 10.2214/AJR.17.19276.
    PubMed     Abstract available


    July 2018
  32. HASSANI C, Ronco A, Prosper AE, Dissanayake S, et al
    Forward-Projected Model-Based Iterative Reconstruction in Screening Low-Dose Chest CT: Comparison With Adaptive Iterative Dose Reduction 3D.
    AJR Am J Roentgenol. 2018 Jul 24:1-9. doi: 10.2214/AJR.17.19245.
    PubMed     Abstract available


    May 2018
  33. KIM HK, Han J, Franks TJ, Lee KS, et al
    Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients.
    AJR Am J Roentgenol. 2018 May 24:W1-W8. doi: 10.2214/AJR.17.19273.
    PubMed     Abstract available


    April 2018
  34. HANSBERRY DR, White MD, D'Angelo M, Prabhu AV, et al
    Lung Cancer Screening Guidelines: How Readable Are Internet-Based Patient Education Resources?
    AJR Am J Roentgenol. 2018 Apr 30:W1-W5. doi: 10.2214/AJR.17.19042.
    PubMed     Abstract available


  35. KISHIDA Y, Seki S, Yoshikawa T, Itoh T, et al
    Performance Comparison Between (18)F-FDG PET/CT Plus Brain MRI and Conventional Staging Plus Brain MRI in Staging of Small Cell Lung Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 18:1-8. doi: 10.2214/AJR.17.18935.
    PubMed     Abstract available


  36. WESSELIUS LJ, DeLeon TT, Gotway MB
    A Sarcoidlike Reaction Mimicking Metastatic Malignancy in a Patient With Melanoma Treated With Pembrolizumab.
    AJR Am J Roentgenol. 2018;210:W183-W184.
    PubMed    


    March 2018
  37. GARCIA-GARRIGOS E, Arenas-Jimenez JJ, Sanchez-Paya J
    Best Protocol for Combined Contrast-Enhanced Thoracic and Abdominal CT for Lung Cancer: A Single-Institution Randomized Crossover Clinical Trial.
    AJR Am J Roentgenol. 2018 Mar 23:1-9. doi: 10.2214/AJR.17.19185.
    PubMed     Abstract available


  38. AVILA NA, Dwyer AJ, Moss J
    Reply to "Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive".
    AJR Am J Roentgenol. 2018;210:W132.
    PubMed    


  39. TROUT AT, Towbin AJ, Franz DN
    Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive.
    AJR Am J Roentgenol. 2018;210:W131.
    PubMed    


    January 2018
  40. LO SB, Freedman MT, Gillis LB, White CS, et al
    JOURNAL CLUB: Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function.
    AJR Am J Roentgenol. 2018 Jan 16:1-8. doi: 10.2214/AJR.17.18718.
    PubMed     Abstract available


    December 2017
  41. LEE C
    Screening for Lung Cancer: Effective Recruitment Methods.
    AJR Am J Roentgenol. 2017 Dec 20:1-4. doi: 10.2214/AJR.17.18755.
    PubMed     Abstract available


  42. CARTER BW, Lichtenberger JP 3rd, Wu CC, Munden RF, et al
    Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers.
    AJR Am J Roentgenol. 2017 Dec 20:1-7. doi: 10.2214/AJR.17.18865.
    PubMed     Abstract available


  43. CHUNG JH, Richards JC, Koelsch TL, MacMahon H, et al
    Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
    AJR Am J Roentgenol. 2017 Dec 12:1-11. doi: 10.2214/AJR.17.19003.
    PubMed     Abstract available


  44. LI M, Narayan V, Gill RR, Jagannathan JP, et al
    Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.
    AJR Am J Roentgenol. 2017;209:1216-1227.
    PubMed     Abstract available


    November 2017
  45. GUICHET PL, Liu BY, Desai B, Surani Z, et al
    Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    AJR Am J Roentgenol. 2017 Nov 22:1-8. doi: 10.2214/AJR.17.18853.
    PubMed     Abstract available


  46. GREEN DB, Pua BB, Crawford CB, Abbey GN, et al
    Screening for Lung Cancer: Communicating With Patients.
    AJR Am J Roentgenol. 2017 Nov 22:1-6. doi: 10.2214/AJR.17.18836.
    PubMed     Abstract available


  47. CHANG S, Hur J, Hong YJ, Lee HJ, et al
    Adverse Prognostic CT Findings for Patients With Advanced Lung Adenocarcinoma Receiving First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy.
    AJR Am J Roentgenol. 2017 Nov 1:1-9. doi: 10.2214/AJR.17.18167.
    PubMed     Abstract available


    October 2017
  48. MOULI SK, Kurilova I, Sofocleous CT, Lewandowski RJ, et al
    The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.
    AJR Am J Roentgenol. 2017;209:740-751.
    PubMed     Abstract available


    September 2017
  49. OHNO Y, Fujisawa Y, Sugihara N, Kishida Y, et al
    Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2017 Sep 20:W1-W10. doi: 10.2214/AJR.17.17959.
    PubMed     Abstract available


  50. PINSKY PF, Gierada DS, Nath PH, Munden R, et al
    Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Sep 12:1-6. doi: 10.2214/AJR.17.18252.
    PubMed     Abstract available


    June 2017
  51. WANG GX, Guo LQ, Gainor JF, Fintelmann FJ, et al
    Immune Checkpoint Inhibitors in Lung Cancer: Imaging Considerations.
    AJR Am J Roentgenol. 2017 Jun 28:1-9. doi: 10.2214/AJR.16.17770.
    PubMed     Abstract available


  52. AHN SY, Park CM, Jeon YK, Kim H, et al
    Predictive CT Features of Visceral Pleural Invasion by T1-Sized Peripheral Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules.
    AJR Am J Roentgenol. 2017 Jun 22:1-6. doi: 10.2214/AJR.16.17280.
    PubMed     Abstract available


  53. LIANG M, Yip R, Tang W, Xu D, et al
    Variation in Screening CT-Detected Nodule Volumetry as a Function of Size.
    AJR Am J Roentgenol. 2017 Jun 1:1-5. doi: 10.2214/AJR.16.17159.
    PubMed     Abstract available


    May 2017
  54. YIP R, Henschke CI, Xu DM, Li K, et al
    Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017;208:1011-1021.
    PubMed     Abstract available


    March 2017
  55. LEE C, Flynn MJ, Judy PF, Cody DD, et al
    Body Size-Specific Organ and Effective Doses of Chest CT Screening Examinations of the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Mar 7:1-7. doi: 10.2214/AJR.16.16979.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: